BioCanRx Rolling call for proposals

Sponsor

Biotherapeutics for Cancer Treatment

Description

Founded in 2015, BioCanRx (Biotherapeutics for Cancer Treatment) is a not-for-profit organization with a mission to improve outcomes for cancer patients by accelerating the development of cost-effective and curative biotherapies. BioCanRx was awarded seed funding of $25 million from the federal government’s Networks of Centres of Excellence (NCE) Program, and has attracted additional tens of millions from partners in all sectors of the economy.

BioCanRx supports biotherapeutic development research through four research programs and a number of core facilities that are accessible to all members of the BioCanRx network. Three of the research programs (Catalyst Projects, Enabling Studies, Clinical Trials) are designed to reflect the translational focus of BioCanRx, which organizes its investments into a pipeline-like structure common to the biotechnology industry. The fourth program (Clinical, Social, and Economic Impact Program) funds research into issues of scientific methodology, clinical trial design, patient engagement, health economics and commercial viability of BioCanRx biotherapeutic platforms and technologies. All research programs are targeted toward applicants who have already made substantial advances in their basic research programs and are now ready to work in collaborative, multidisciplinary, academic–industry teams to move their discoveries into the clinic in a rational, scientifically well-supported and highly disciplined fashion. 

Eligibility

All investigators located at Canadian institutions eligible to receive peer-reviewed funding from the three federal research-granting councils (CIHR, SSHRC, NSERC).

Funding Availability

BioCanRx was awarded seed funding of $25 million from the federal government’s Networks of Centres of Excellence (NCE) Program, and has attracted additional tens of millions from partners in all sectors of the economy.

Indirect Costs

0%

Special Notes

BioCanRx uses a rolling open call that starts with a letter-of-intent stage and has submission deadlines that are structured around the meeting dates of our Research Management Committee.

Deadlines

If College-level review is required, your College will communicate its earlier internal deadlines.

TypeNotes
Internal Deadline

One week prior to submission of application (if invited) to sponsor, send an OR-5 form along with a copy of application to research.services@uoguelph.ca.

 

External Deadline

Rolling call 

Recommended process:

  • Step 1: Query phase;
  • Step 2: Letter of intent phase;
  • Step 3: Submission of full application  (by invitation only).

More information can be found at BioCanRX.

How to Apply

The completed letter of intent (LOI) application must be delivered by email to applications@biocanrx.com.

If invited, the application package must be delivered by email to applications@biocanrx.com.

Information For Co-applicants

If you need to meet a deadline set by the lead institution for this opportunity, please ensure that you provide the Office of Research with at least five days in advance of the lead institution’s deadline to review the application, or your proposed component of the project. Please be in touch with the Office of Research (contact information below) ahead of the deadline if it looks like it will be difficult for you to submit all the required documentation on time (i.e. budget, proposal, OR-5 Form).

For Questions, please contact

Kelley Parato
BioCanRx Director, Scientific Affairs
keparato@biocanrx.com
(613) 739-6595

or

Stéphanie Michaud
BioCanRx President and Chief Executive Officer
smichaud@biocanrx.com
(613) 739-6202

Office of Research

Ornella McCarron, Grants Officer
Office of Research Services
519-824-4120 x52832
omccarro@uoguelph.ca

Alert Classifications
Category:
Funding Opportunities and Sponsor News

Disciplines:
Health and Life Sciences